February 20, 2025 Is GLP-1RA Use Tied to Short-Term Thyroid Cancer Risk? Study authors attributed the increased cancer risk to greater medical scrutiny rather than a biological effect. Conexiant
February 19, 2025 Recurrent Hyperpigmented Patches After GLP-1 Therapy: What's Your Diagnosis? Conexiant
February 17, 2025 Dual Immunotherapy Extended Progression-Free Survival in Metastatic Colorectal Cancer Subgroup The ASCO Post
February 13, 2025 Everolimus/Lanreotide vs Everolimus in Gastroenteropancreatic Neuroendocrine Tumors The ASCO Post
February 17, 2025 Imlunestrant Alone or With Abemaciclib: An All-Oral Targeted Therapy for ER-Positive Advanced Breast Cancer The ASCO Post
January 03, 2025 Imlunestrant, Alone and Combined With Abemaciclib, Effective in ESR1-Mutated Breast Cancer The ASCO Post
January 22, 2025 Imlunestrant Alone or With Abemaciclib: An All-Oral Targeted Therapy for ER-Positive Advanced Breast Cancer The ASCO Post
January 23, 2025 Managing Comorbidities in Oncology: Practical Strategies for Optimized Patient Care The ASCO Post
January 28, 2025 T-DXd Approved by the FDA for Pretreated Patients With HER2-Low or -Ultralow Metastatic Breast Cancer The ASCO Post
February 04, 2025 FDA Approves Clinical Trials for Genetically Modified Pig Kidney Transplants Conexiant